...
首页> 外文期刊>International immunopharmacology >4-Methoxylonchocarpin attenuates inflammation by inhibiting lipopolysaccharide binding to Toll-like receptor of macrophages and M1 macrophage polarization
【24h】

4-Methoxylonchocarpin attenuates inflammation by inhibiting lipopolysaccharide binding to Toll-like receptor of macrophages and M1 macrophage polarization

机译:通过抑制巨噬细胞和M1巨噬细胞极化的Toll样受体抑制脂多糖结合,4-甲氧基因丙氨酸通过抑制脂多糖结合而衰减炎症

获取原文
获取原文并翻译 | 示例
           

摘要

The roots of Abrus precatorius (AP, Fabaceae) have traditionally been used in Vietnam and China for the treatment of inflammatory diseases such as stomatitis, asthma, bronchitis, and hepatitis. Therefore, in this study, we isolated 4-methoxylonchocarpin (ML), an anti-inflammatory compound present in AP, and studied its anti-inflammatory effects in mice with 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis. In lipopolysaccharide (LPS)-stimulated macrophages, ML was found to inhibit nuclear factor (NF)-kappa B activation and tumor necrosis factor (TNF) and interleuldn (IL)-6 expression by inhibiting LPS binding to Toll-like receptor 4 (TLR4) in vitro. Oral administration of ML in mice with TNBS-induced colitis suppressed colon shortening and colonic myeloperoxidase activity. ML treatment significantly inhibited the activation of nuclear factor (NF)-kappa B and phosphorylation of transforming growth factor (beta-activated kinase 1 in the colon. Treatment with ML also inhibited TNBS-induced expression of IL -1 beta(3, IL-17A, and TNF. While ML reduced the TNBS-induced expression of M1 macrophage markers such as arginase-2 and TNF, it was found to increase the expression of M2 macrophage markers such as arginase- and IL-10. In conclusion, oral administration of ML attenuated colitis in mice by inhibiting the binding of LPS to TLR4 on immune cells and increasing the polarization of M1 macrophages to M2 macrophages. (C) 2017 Elsevier B.V. All rights reserved.
机译:Abrus Precatorius(AP,Fabaceae)的根源传统上用于越南和中国,用于治疗炎症性疾病,如口腔炎,哮喘,支气管炎和肝炎。因此,在该研究中,我们分离出4-甲氧基因素(mL),存在于AP中的抗炎化合物,并研究其在小鼠中的抗炎作用,其中2,4,6-三硝基苯磺酸(TNBs)诱导的结肠炎。在脂多糖(LPS)刺激的巨噬细胞中,发现ML通过抑制与Toll样受体4的LPS结合(TLR4 ) 体外。具有TNBS诱导的结肠炎的小鼠中M1的口服给药抑制了结肠缩短和结肠髓过氧化物酶活性。 ml治疗显着抑制核因子(NF)-kappa B的激活和转化生长因子的磷酸化(结肠中的β-活性激酶1。用ml处理也抑制TNBS诱导的IL-1β(3,IL- 17A和TNF。虽然M1减少了TNBS诱导的M1巨噬细胞标记物的表达,例如AgInase-2和TNF,但发现M2巨噬细胞标记物如氨基酶和IL-10的表达。总之,口服给药通过抑制LPS对TLR4对免疫细胞的结合并增加M1巨噬细胞的极化对M2巨噬细胞的抗体的含量。(c)2017年Elsevier BV保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号